Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2018 | 1 |
2019 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131.
N Engl J Med. 2023.
PMID: 37256976
Clinical Trial.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators.
von Minckwitz G, et al.
N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5.
N Engl J Med. 2019.
PMID: 30516102
Clinical Trial.
Item in Clipboard
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial.
Loibl S, Marmé F, Martin M, Untch M, Bonnefoi H, Kim SB, Bear H, McCarthy N, Melé Olivé M, Gelmon K, García-Sáenz J, Kelly CM, Reimer T, Toi M, Rugo HS, Denkert C, Gnant M, Makris A, Koehler M, Huang-Bartelett C, Lechuga Frean MJ, Colleoni M, Werutsky G, Seiler S, Burchardi N, Nekljudova V, von Minckwitz G.
Loibl S, et al. Among authors: mele olive m.
J Clin Oncol. 2021 May 10;39(14):1518-1530. doi: 10.1200/JCO.20.03639. Epub 2021 Apr 1.
J Clin Oncol. 2021.
PMID: 33793299
Clinical Trial.
Item in Clipboard
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators.
Miles D, et al.
Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2.
Ann Oncol. 2021.
PMID: 34224826
Free article.
Clinical Trial.
Item in Clipboard
Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node.
Fuertes Manuel J, Kohan S, Jordà Solé M, Mateu Hidalgo I, Miralles Curto M, Aguiló Sagristà O, Aguilar Alomá E, Peña González K, Lafuerza Torres A, Melé Olivé M, Repkova J, Montero Jaime MJ, Gumà Padró J.
Fuertes Manuel J, et al. Among authors: mele olive m.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Sep-Oct;41(5):284-291. doi: 10.1016/j.remnie.2022.05.002. Epub 2022 May 18.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022.
PMID: 35597764
Item in Clipboard
Fatal pneumonitis induced by oxaliplatin.
Arévalo Lobera S, Sagastibeltza Mariñelarena N, Elejoste Echeberría I, Melé Olivé M, Egaña Otaño L, Basterretxea Badiola L, La Casta Muñoa A, Azkue Gabilondo M.
Arévalo Lobera S, et al. Among authors: mele olive m.
Clin Transl Oncol. 2008 Nov;10(11):764-7. doi: 10.1007/s12094-008-0285-7.
Clin Transl Oncol. 2008.
PMID: 19015075
Item in Clipboard
Cite
Cite